🇺🇸 FDA
Patent

US 10758530

Carboxamide derivatives useful as rsk inhibitors

granted A61KA61K31/337A61K31/4355

Quick answer

US patent 10758530 (Carboxamide derivatives useful as rsk inhibitors) held by PHOENIX MOLECULAR DESIGNS expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PHOENIX MOLECULAR DESIGNS
Grant date
Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/337, A61K31/4355, A61K31/437, A61K31/496